McKesson/$MCK
1D1W1MYTD1Y5YMAX
Capital at risk
About McKesson
McKesson is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
- Ticker
- $MCK
- Sector
- Health
- Primary listing
- NYSE
- Employees
- 42,300
- Headquarters
- Irving, United States
- Website
- www.mckesson.com
McKesson Metrics
BasicAdvanced
$103B
23.50
$37.48
0.31
$3.28
0.37%
Price and volume
Market cap
$103B
Beta
0.31
52-week high
$999.00
52-week low
$687.68
Average daily volume
974K
Dividend rate
$3.28
Financial strength
Current ratio
0.893
Quick ratio
0.504
Long term debt to equity
-778.478
Total debt to equity
-906.687
Dividend payout ratio (TTM)
8.56%
Interest coverage (TTM)
23.83%
Profitability
EBITDA (TTM)
7,071
Gross margin (TTM)
3.64%
Net profit margin (TTM)
1.12%
Operating margin (TTM)
1.57%
Effective tax rate (TTM)
17.93%
Revenue per employee (TTM)
$9,720,000
Management effectiveness
Return on assets (TTM)
4.83%
Return on equity (TTM)
-489.83%
Valuation
Price to earnings (TTM)
23.501
Price to revenue (TTM)
0.262
Price to book
-24.1
Price to tangible book (TTM)
-5.23
Price to free cash flow (TTM)
17.495
Free cash flow yield (TTM)
5.72%
Free cash flow per share (TTM)
50.348
Dividend yield (TTM)
0.37%
Forward dividend yield
0.37%
Growth
Revenue change (TTM)
8.84%
Earnings per share change (TTM)
50.20%
3-year revenue growth (CAGR)
13.10%
10-year revenue growth (CAGR)
7.85%
3-year earnings per share growth (CAGR)
11.82%
10-year earnings per share growth (CAGR)
14.56%
3-year dividend per share growth (CAGR)
14.94%
10-year dividend per share growth (CAGR)
11.34%
What the Analysts think about McKesson
Analyst ratings (Buy, Hold, Sell) for McKesson stock.
Analyst projections of the future price of McKesson stock.
Bulls say / Bears say
Adjusted EPS for fiscal Q2 rose 39% year-on-year to $9.86, beating the consensus estimate of $9.04 and demonstrating strong profitability growth (Reuters)
McKesson raised its fiscal 2026 adjusted EPS guidance to $38.35–$38.85 from $38.05–$38.55, signaling management’s confidence in sustained earnings growth (Reuters)
Oncology & Multispecialty segment revenue grew 32% year-on-year, driven by specialty distribution expansion and recent acquisitions, reflecting successful diversification into higher-margin businesses (Reuters)
Fiscal Q2 revenue of $103.15 billion slightly missed the $104.13 billion consensus, suggesting potential volatility in core pharmaceutical distribution volumes (Reuters)
Shares trade at 20 times forward earnings, up from 18 times three months ago, indicating stretched valuation that could face pressure if growth moderates (Reuters)
Customer concentration remains high, with the top ten customers accounting for 73% of revenues and CVS alone representing 24%, exposing McKesson to counterparty risk if key relationships sour (10-K)
Data summarised monthly by Lightyear AI. Last updated on 24 Aug 2026.
McKesson Financial Performance
Revenues and expenses
McKesson Earnings Performance
Company profitability
Upcoming events
McKesson News
AllArticlesVideos
McKesson Eyes $2.25B Precision Medicine Deal as Oncology Growth Accelerates
MarketBeat4 days ago
Hackers claim millions of patient records stolen during data breach at healthcare giant McKesson
TechCrunch2 weeks ago
McKesson Buys Precision Medicine to Expand Clinical Research and Commercialization
Benzinga3 weeks ago
Funds containing McKesson
AllEURUSDGBP
Fund name | Fund size | $MCK weighting |
|---|---|---|
iShares MSCI World Health Care Sector Advanced€CBUF | €606M | 1.93% |
iShares S&P 500 Health Care Sector€IUHE | €125M | 1.77% |
iShares Edge MSCI World Minimum Volatility$MVOL | $2.6B | 1.03% |
iShares Edge MSCI World Minimum Volatility€IQQ0 | €2.3B | 1.03% |
iShares Edge MSCI World Minimum Volatility£MINV | £1.9B | 1.03% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.